These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30148069)

  • 21. Breast cancer cells: Modulation by melatonin and the ubiquitin-proteasome system--a review.
    Vriend J; Reiter RJ
    Mol Cell Endocrinol; 2015 Dec; 417():1-9. PubMed ID: 26363225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer.
    Tang SC; Lion Q; Peulen O; Chariot P; Lavergne A; Mayer A; Fuster PA; Close P; Klein S; Florin A; Büttner R; Nemazanyy I; Shostak K; Chariot A
    Oncogene; 2022 Jan; 41(2):173-190. PubMed ID: 34716429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of an estrogen receptor α non covalent ubiquitin-binding surface: role in 17β-estradiol-induced transcriptional activity.
    Pesiri V; La Rosa P; Stano P; Acconcia F
    J Cell Sci; 2013 Jun; 126(Pt 12):2577-82. PubMed ID: 23591816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heat shock factor 1 (HSF1) cooperates with estrogen receptor α (ERα) in the regulation of estrogen action in breast cancer cells.
    Vydra N; Janus P; Kus P; Stokowy T; Mrowiec K; Toma-Jonik A; Krzywon A; Cortez AJ; Wojtas B; Gielniewski B; Jaksik R; Kimmel M; Widlak W
    Elife; 2021 Nov; 10():. PubMed ID: 34783649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel 11β-substituted estradiol conjugates: Transition from ERα agonizts to effective PROTAC degraders.
    Luo G; Li X; Lin X; Lu X; Li Z; Xiang H
    J Steroid Biochem Mol Biol; 2022 Oct; 223():106154. PubMed ID: 35870675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactions.
    Herynk MH; Hopp T; Cui Y; Niu A; Corona-Rodriguez A; Fuqua SA
    Breast Cancer Res Treat; 2010 Jul; 122(2):381-93. PubMed ID: 19842032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.
    Liu H; Qiu J; Li N; Chen T; Cao X
    J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor-alpha-interacting cytokeratins potentiate the antiestrogenic activity of fulvestrant.
    Long X; Fan M; Nephew KP
    Cancer Biol Ther; 2010 Mar; 9(5):389-96. PubMed ID: 20061804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety.
    Han SJ; Begum K; Foulds CE; Hamilton RA; Bailey S; Malovannaya A; Chan D; Qin J; O'Malley BW
    Mol Pharmacol; 2016 Jan; 89(1):14-26. PubMed ID: 26487511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer.
    Anbalagan M; Rowan BG
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 3():264-72. PubMed ID: 25597633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy.
    Yu EJ; Kim SH; Heo K; Ou CY; Stallcup MR; Kim JH
    Nucleic Acids Res; 2011 Sep; 39(16):6932-43. PubMed ID: 21596782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repression of estrogen receptor alpha by CDK11p58 through promoting its ubiquitin-proteasome degradation.
    Wang Y; Zong H; Chi Y; Hong Y; Yang Y; Zou W; Yun X; Gu J
    J Biochem; 2009 Mar; 145(3):331-43. PubMed ID: 19122208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
    Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors.
    Kalet BT; Anglin SR; Handschy A; O'Donoghue LE; Halsey C; Chubb L; Korch C; Duval DL
    PLoS One; 2013; 8(7):e68815. PubMed ID: 23874775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer.
    Cao J; Wang X; Wang S; Chen Z; Tang J
    Cancer Sci; 2023 May; 114(5):2041-2052. PubMed ID: 36221793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha.
    Fan M; Park A; Nephew KP
    Mol Endocrinol; 2005 Dec; 19(12):2901-14. PubMed ID: 16037132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
    Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I
    Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of ERα Stability and Estrogen Signaling in Breast Cancer by HOIL-1.
    Ding J; Kuang P
    Front Oncol; 2021; 11():664689. PubMed ID: 34094957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus.
    Valley CC; Métivier R; Solodin NM; Fowler AM; Mashek MT; Hill L; Alarid ET
    Mol Cell Biol; 2005 Jul; 25(13):5417-28. PubMed ID: 15964799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.